info icon

Medicines for HER+ breast cancer

RX_ERPLUS

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC L02B[AG]

1 out of 7 registries used, show all original rules.

10677

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

10677

diagram downward connector

Include endpoints None

10677

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

10382

diagram downward connector
RX_ERPLUS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF9

Summary Statistics

Key figures

All Female Male
Number of individuals 10382 10225 157
Unadjusted prevalence (%) 2.75 4.85 0.09
Mean age at first event (years) 60.49 60.61 52.63

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: RX_ERPLUS – Medicines for HER+ breast cancer
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Medicines for HER+ breast cancer

Endpoint not on priority list, no data to show.